Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Glasgow Precision Oncology Laboratory"'
Autor:
Dreyer, Stephan B., Upstill-Goddard, Rosie, Paulus-Hock, Viola, Paris, Clara, Lampraki, Eirini-Maria, Dray, Eloise, Serrels, Bryan, Caligiuri, Giuseppina, Rebus, Selma, Plenker, Dennis, Galluzzo, Zachary, Brunton, Holly, Cunningham, Richard, Tesson, Mathias, Nourse, Craig, Bailey, Ulla-Maja, Jones, Marc, Moran-Jones, Kim, Wright, Derek W., Duthie, Fraser, Oien, Karin, Evers, Lisa, McKay, Colin J., McGregor, Grant A., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephan, Dziubinski, Michele L., Candido, Juliana, Balkwill, Frances, Barry, Simon T., Grützmann, Robert, Rahib, Lola, Glasgow Precision Oncology Laboratory, Australian Pancreatic Cancer Genome Initiative, Johns, Amber, Pajic, Mariana, Froeling, Fieke E.M., Beer, Phillip, Musgrove, Eilzabeth A., Petersen, Gloria M., Ashworth, Alan, Frame, Margaret C., Crawford, Howard C., Simeone, Diane M., Lord, Chris, Mukhopadhyay, Debabrata, Pilarsky, Christian, Tuveson, David A., Cooke, Susanna L., Jamieson, Nigel B., Morton, Jennifer P., Sansom, Owen J., Bailey, Peter J., Biankin, Andrew V., Chang, David K.
Background and aims:\ud Continuing recalcitrance to therapy cements pancreatic cancer (PC) as the most lethal malignancy, which is set to become the second leading cause of cancer death in our society. The study aim was to investigate the association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::6d727117711a10a56fec75bd0f3b65e3
https://eprints.gla.ac.uk/223681/3/223681.pdf
https://eprints.gla.ac.uk/223681/3/223681.pdf
Autor:
Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosie Upstill-Goddard, Ulla-Maja Bailey, Ian M. Garner, Craig Nourse, Stephan Dreyer, Marc Jones, Kim Moran-Jones, Derek W. Wright, Viola Paulus-Hock, Colin Nixon, Gemma Thomson, Nigel Jamieson, Grant A. McGregor, Lisa Evers, Colin J. McKay, Aditi Gulati, Rachel Brough, Ilirjana Bajrami, Stephen Pettit, Michele L. Dziubinski, Simon T. Barry, Robert Grützmann, Robert Brown, Edward Curry, Glasgow Precision Oncology Laboratory, Australian Pancreatic Cancer Genome Initiative, Marina Pajic, Elizabeth A. Musgrove, Gloria Petersen, Emma Shanks, Alan Ashworth, Howard C. Crawford, Diane M. Simeone, Fieke E.M. Froeling, Christopher J. Lord, Debabrata Mukhopadhyay, Christian Pilarsky, Sean E. Grimmond, Jennifer P. Morton, Owen J. Sansom, David K. Chang, Peter Bailey, Andrew V. Biankin
Publikováno v:
SSRN Electronic Journal.
The identification of molecularly defined subgroups of Pancreatic ductal Adenocarcinoma (PDAC) has the potential to transform clinical practice. There is now a growing consensus that PDAC can be divided into transcriptomic subtypes with 2 broad linag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::775f120d1a30418ec9c42c5feac9a429
https://doi.org/10.2139/ssrn.3430714
https://doi.org/10.2139/ssrn.3430714
Autor:
Pujol P; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France; CREEC, UMR IRD 224-CNRS 5290 Université Montpellier, Montpellier, France. Electronic address: p-pujol@chu-montpellier.fr., Barberis M; Pathology Unit, European Institute of Oncology, Milan, Italy. Electronic address: Massimo.barberis@ieo.it., Beer P; Wellcome Trust Sanger institute, Cambridge, United Kingdom; Glasgow Precision Oncology Laboratory, United Kingdom. Electronic address: pbeer@doctors.org.uk., Friedman E; The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. Electronic address: Eitan.Friedman@sheba.health.gov.il., Piulats JM; Unidad Funcional de Cáncer de Próstata, Servicio de Oncología Médica, Hospital Universitari de Bellvitge-Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain; Servicio de Oncología Médica, Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Spain. Electronic address: jmpiulats@iconcologia.net., Capoluongo ED; Dipartimento di Medicina Molecolare e Biotecnologie Mediche Università Federico II, CEINGE Biotecnologie Avanzate, Naples, 80145, Italy. Electronic address: ettoredomenico.capoluongo@unina.it., Garcia Foncillas J; Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jimenez Diaz-UAM, Madrid, Spain. Electronic address: jesus.garciafoncillas@oncohealth.eu., Ray-Coquard I; Oncologie Médicale, Centre Leon Bérard; Univ Lyon, Université Claude Bernard Lyon1, Hesper EA 7425, F - 69003, Lyon, France. Electronic address: Isabelle.Ray-Coquard@lyon.unicancer.fr., Penault-Llorca F; Department of Biology and Pathology, Centre Jean Perrin, Clermont Ferrand, France; UMR INSERM 1240, Université Clermont Auvergne, Clermont Ferrand, France. Electronic address: Frederique.PENAULT-LLORCA@cjp.fr., Foulkes WD; McGill University, Division of Medical Genetics, Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada. Electronic address: william.foulkes@mcgill.ca., Turnbull C; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK; Genomics England, Queen Mary University of London, London, UK; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Clare.Turnbull@genomicsengland.co.uk., Hanson H; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK. Electronic address: helen.hanson@icr.ac.uk., Narod S; University of Toronto Dalla Lana School of Public Health, Toronto, ON, Canada; Canada Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada. Electronic address: Steven.Narod@wchospital.ca., Arun BK; Anderson Cancer Center, The University of Texas, Department of Breast Medical Oncology, Division of Cancer Medicine, USA. Electronic address: barun@mdanderson.org., Aapro MS; IMO Clinique de Genolier, Genolier, Switzerland. Electronic address: Maapro@genolier.net., Mandel JL; Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France; Université de Strasbourg, Illkirch, France. Electronic address: jlmandel@igbmc.fr., Normanno N; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, Naples, Italy. Electronic address: n.normanno@istitutotumori.na.it., Lambrechts D; Laboratory of Translational Genetics (VIB-KU Leuven), ON IV Herestraat 49 - box 912, 3000, Leuven Belgium. Electronic address: diether.lambrechts@kuleuven.vib.be., Vergote I; Department of Gynaecologic Oncology University Hospitals Leuven, Gasthuisberg Herestraat 49, 3000 Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Anahory M; Pech de Laclause, Bathmanabane & Associés Law Firm, Paris, France. Electronic address: manahory@pechdelaclause.com., Baertschi B; French National Institute for Health and Medical Research (INSERM) Ethics Committee, France University of Geneva, Geneva, Switzerland. Electronic address: bernard.baertschi@unige.ch., Baudry K; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: k-baudry@chu-montpellier.fr., Bignon YJ; Department of Oncogenetics, Centre Jean Perrin, CBRV, Clermont-Ferrand, France; INSERM-U1240-Molecular Imaging and Theranostic Strategies (IMOST), Clermont-Ferrand, France. Electronic address: Yves-Jean.Bignon@cjp.fr., Bollet M; Institut Hartmann, 4, rue Kléber, et Institut Rafael, 3 bd Bineau, 92309 Levallois-Perret cedex, France. Electronic address: marc.bollet@horg.fr., Corsini C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-corsini@chu-montpellier.fr., Cussenot O; CeRePP, Hopital Tenon, Paris, France; Sorbonne Université, Institut Universitaire de Cancérologie, GRC n°5 ONCOTYPE-URO, Hopital Tenon, APHP, Paris, France; Department of Urology, Assistance Publique- Hôpitaux de Paris, Hopital Tenon, Paris, France. Electronic address: olivier.cussenot@tnn.aphp.fr., De la Motte Rouge T; Inserm, Oncogenesis, Stress and Signaling, 35000 Rennes, France; Service d'oncologie médicale, CRLCC Eugène-Marquis, 35000 Rennes, France; UMR 1242, Inserm, Univ Rennes, CLCC Eugène Marquis, Rue Bataille Flandres Dunkerque, 35042, Rennes, France. Electronic address: t.delamotterouge@rennes.unicancer.fr., Duboys de Labarre M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-duboysdelabarre@chu-montpellier.fr., Duchamp F; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: f-duchamp@chu-montpellier.fr., Duriez C; BRCA France Association, France. Electronic address: duriez.clarisse@gmail.com., Fizazi K; Institut Gustave Roussy and University of Paris Sud, Villejuif, France. Electronic address: karim.FIZAZI@gustaveroussy.fr., Galibert V; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: v-galibert@chu-montpellier.fr., Gladieff L; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address: Gladieff.Laurence@iuct-oncopole.fr., Gligorov J; APHP-Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr., Hammel P; Department of Pancreatology, Hôpital Beaujon (AP-HP), Université Denis Diderot-Paris VII, Clichy, France. Electronic address: pascal.hammel@bjn.aphp.fr., Imbert-Bouteille M; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: m-imbert-bouteille@chu-montpellier.fr., Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France. Electronic address: William.Jacot@icm.unicancer.fr., Kogut-Kubiak T; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: t-kogutkubiak@chu-montpellier.fr., Lamy PJ; Institut d'analyse génomique-Imagenome, Labosud, Montpellier, France. Electronic address: pierre-jean.lamy@labosud.fr., Nambot S; Centre de Génétique et Centre de Référence Maladies Rares (Anomalies du Développement de l'Interrégion Est), Hôpital d'Enfants, CHU Dijon Bourgogne, Dijon, France; Inserm UMR 1231 GAD (Génétique des Anomalies du Développement), Université de Bourgogne, Dijon, France; Fédération Hospitalo-Universitaire Médecine Translationnelle et Anomalies du Développement (FHU TRANSLAD), CHU Dijon Bourgogne et Université de Bourgogne-Franche Comté, Dijon, France. Electronic address: sophie.nambot@chu-dijon.fr., Neuzillet Y; Service d'urologie et de transplantation rénale, hôpital Foch, université de Versailles - Saint-Quentin-en-Yvelines, 40, rue Worth, 92150 Suresnes, France. Electronic address: y.neuzillet@hopital-foch.org., Olschwang S; Aix Marseille Université, INSERM GMGF UMR 1251, France; Département de Génétique Médicale, Hôpital Européen & Groupe Ramsay Générale de Santé, Hôpital Clairval, Aix Marseille Université, Marseille, France. Electronic address: solschwang@gmail.com., Rebillard X; Service d'Urologie, Clinique Beausoleil, Montpellier, France. Electronic address: xavier.rebillard@wanadoo.fr., Rey JM; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: jm-rey@chu-montpellier.fr., Rideau C; Department of Cancer Genetics, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: c-rideau@chu-montpellier.fr., Spano JP; Department of Medical Oncology, Hôpital Pitié Salpêtrière, APHP, Sorbonne Université, Paris, France; Inserm UMRS 1136, Sorbonne Université, Paris, France. Electronic address: jean-philippe.spano@psl.aphp.fr., Thomas F; IRD, CREEC et MIVE911 avenue Agropolis, BP 64501, Montpellier 34 394, France. Electronic address: frederic.thomas2@ird.fr., Treilleux I; Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373, Lyon Cédex 08, France. Electronic address: isabelle.treilleux@lyon.unicancer.fr., Vandromme M; BRCA France Association, France. Electronic address: marion.vandromme@gmail.com., Vendrell J; IRCM, INSERM 1194, Department of Pathology and Oncobiology, Laboratoire de biologie des tumeurs solides, CHU Montpellier, Univ Montpellier, Montpellier, France. Electronic address: j-vendrell@chu-montpellier.fr., Vintraud M; Department of Radiotherapy, Hartmann Radiotherapy Center, Levallois-Perret, France. Electronic address: michelevintraud@live.fr., Zarca D; The Paris Breast Centre- L'Institut Français du Sein- 15 rue Jean Nicot, 75007, Paris, France. Electronic address: daniel.zarca@gmail.com., Hughes KS; Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: kshughes@partners.org., Alés Martínez JE; Medical Oncology Department, Hospital Nuestra Señora de Sonsoles, Ávila, Ávila, Spain. Electronic address: jealesm@yahoo.es.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Mar; Vol. 146, pp. 30-47. Date of Electronic Publication: 2021 Feb 10.
Autor:
Miller RE; Department of Medical Oncology, University College London, London, UK; Department of Medical Oncology, St Bartholomew's Hospital, London, UK., Leary A; Department of Medicine and INSERM U981, Gustave Roussy Cancer Center, Université Paris-Saclay, Paris, France., Scott CL; Peter MacCallum Cancer Centre, Melbourne, Australia; The University of Melbourne, Melbourne, Australia., Serra V; Experimental Therapeutics Group Vall d'Hebron Institute of Oncology, Barcelona, Spain., Lord CJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK; CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, Australia; The University of Melbourne, Melbourne, Australia., Chang DK; Glasgow Precision Oncology Laboratory, Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, UK., Garsed DW; Peter MacCallum Cancer Centre, Melbourne, Australia; The University of Melbourne, Melbourne, Australia., Jonkers J; Division of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands., Ledermann JA; UCL Cancer Institute, University College London, London, UK., Nik-Zainal S; Department of Medical Genetics, School of Clinical Medicine, University of Cambridge, Cambridge, UK; MRC Cancer Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK., Ray-Coquard I; Centre Leon Berard, Lyon, France; University Claude Bernard Groupe University of Lyon, France., Shah SP; Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA., Matias-Guiu X; Departments of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, Universities of Lleida and Barcelona, Irblleida, Idibell, Ciberonc, Barcelona, Spain., Swisher EM; Department of Obstetrics and Gynecology, University of Washington, Seattle, USA., Yates LR; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge; Guy's Cancer Centre, Guys and St Thomas' NHS Foundation Trust, London, UK. Electronic address: education@esmo.org.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Dec; Vol. 31 (12), pp. 1606-1622. Date of Electronic Publication: 2020 Sep 28.
Autor:
Steins A; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Mackelenbergh MG; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van der Zalm AP; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Klaassen R; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Serrels B; Wolfson Wohl Cancer Research Centre, Glasgow Precision Oncology Laboratory, University of Glasgow, Glasgow, UK., Goris SG; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Kocher HM; Centre for Tumor Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Waasdorp C; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., de Jong JH; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Tekin C; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van de Vijver MJ; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Verheij J; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Dijk F; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Tienhoven G; Department of Radiation Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Medema JP; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Laarhoven HW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
EMBO reports [EMBO Rep] 2020 May 06; Vol. 21 (5), pp. e48780. Date of Electronic Publication: 2020 Mar 16.